Dyne Therapeutics Stock Forward View - Simple Moving Average
| DYN Stock | USD 17.89 0.01 0.06% |
Dyne Stock outlook is based on your current time horizon.
As of today, the value of RSI of Dyne Therapeutics' share price is approaching 45 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Dyne Therapeutics, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
Using Dyne Therapeutics hype-based prediction, you can estimate the value of Dyne Therapeutics from the perspective of Dyne Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Dyne Therapeutics on the next trading day is expected to be 17.89 with a mean absolute deviation of 0.65 and the sum of the absolute errors of 38.62. Dyne Therapeutics after-hype prediction price | USD 17.89 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Dyne Therapeutics to cross-verify your projections. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.Dyne Therapeutics Additional Predictive Modules
Most predictive techniques to examine Dyne price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dyne using various technical indicators. When you analyze Dyne charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Dyne Therapeutics Simple Moving Average Price Forecast For the 2nd of February
Given 90 days horizon, the Simple Moving Average forecasted value of Dyne Therapeutics on the next trading day is expected to be 17.89 with a mean absolute deviation of 0.65, mean absolute percentage error of 0.81, and the sum of the absolute errors of 38.62.Please note that although there have been many attempts to predict Dyne Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Dyne Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Dyne Therapeutics Stock Forecast Pattern
| Backtest Dyne Therapeutics | Dyne Therapeutics Price Prediction | Research Analysis |
Dyne Therapeutics Forecasted Value
In the context of forecasting Dyne Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Dyne Therapeutics' downside and upside margins for the forecasting period are 13.26 and 22.52, respectively. We have considered Dyne Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Dyne Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Dyne Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.2208 |
| Bias | Arithmetic mean of the errors | 0.0818 |
| MAD | Mean absolute deviation | 0.6545 |
| MAPE | Mean absolute percentage error | 0.034 |
| SAE | Sum of the absolute errors | 38.615 |
Predictive Modules for Dyne Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dyne Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dyne Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Dyne Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dyne Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Dyne Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Dyne Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Dyne Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dyne Therapeutics' historical news coverage. Dyne Therapeutics' after-hype downside and upside margins for the prediction period are 13.26 and 22.52, respectively. We have considered Dyne Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Dyne Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Dyne Therapeutics is based on 3 months time horizon.
Dyne Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Dyne Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dyne Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dyne Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.37 | 4.63 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
17.89 | 17.89 | 0.00 |
|
Dyne Therapeutics Hype Timeline
On the 1st of February Dyne Therapeutics is traded for 17.89. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Dyne is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.37%. %. The volatility of related hype on Dyne Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 17.89. About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Dyne Therapeutics was currently reported as 4.85. The company has Price/Earnings To Growth (PEG) ratio of 0.19. Dyne Therapeutics recorded a loss per share of 3.62. The entity last dividend was issued on the May 30, 2002. The firm had 1:5 split on the May 25, 2010. Considering the 90-day investment horizon the next anticipated press release will be in a few days. Check out Historical Fundamental Analysis of Dyne Therapeutics to cross-verify your projections. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.Dyne Therapeutics Related Hype Analysis
Having access to credible news sources related to Dyne Therapeutics' direct competition is more important than ever and may enhance your ability to predict Dyne Therapeutics' future price movements. Getting to know how Dyne Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dyne Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RARE | Ultragenyx | 0.00 | 0 per month | 0.00 | (0.05) | 7.73 | (4.09) | 51.23 | |
| SLNO | Soleno Therapeutics | 0.00 | 0 per month | 0.00 | (0.17) | 5.16 | (4.91) | 26.59 | |
| CNTA | Centessa Pharmaceuticals PLC | 0.00 | 0 per month | 2.49 | 0.02 | 4.97 | (3.15) | 26.54 | |
| XENE | Xenon Pharmaceuticals | 0.00 | 0 per month | 1.97 | (0.01) | 3.78 | (2.71) | 10.56 | |
| APGE | Apogee Therapeutics Common | 0.00 | 0 per month | 2.66 | 0.1 | 4.52 | (2.64) | 23.21 | |
| AAPG | Ascentage Pharma Group | 0.00 | 0 per month | 0.00 | (0.16) | 5.25 | (6.36) | 16.72 | |
| MIRM | Mirum Pharmaceuticals | 0.00 | 0 per month | 1.67 | 0.23 | 4.60 | (3.38) | 13.83 | |
| CELC | Celcuity LLC | 0.00 | 0 per month | 1.95 | 0.20 | 5.87 | (2.92) | 17.89 | |
| TLX | Telix Pharmaceuticals Limited | 0.00 | 0 per month | 0.00 | (0.20) | 4.24 | (5.43) | 15.35 | |
| CGON | CG Oncology Common | 0.00 | 0 per month | 2.59 | 0.08 | 5.15 | (4.40) | 33.66 |
Other Forecasting Options for Dyne Therapeutics
For every potential investor in Dyne, whether a beginner or expert, Dyne Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dyne Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dyne. Basic forecasting techniques help filter out the noise by identifying Dyne Therapeutics' price trends.Dyne Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dyne Therapeutics stock to make a market-neutral strategy. Peer analysis of Dyne Therapeutics could also be used in its relative valuation, which is a method of valuing Dyne Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dyne Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Dyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dyne Therapeutics shares will generate the highest return on investment. By undertsting and applying Dyne Therapeutics stock market strength indicators, traders can identify Dyne Therapeutics entry and exit signals to maximize returns.
Dyne Therapeutics Risk Indicators
The analysis of Dyne Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dyne Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dyne stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.24 | |||
| Standard Deviation | 4.63 | |||
| Variance | 21.41 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Dyne Therapeutics
The number of cover stories for Dyne Therapeutics depends on current market conditions and Dyne Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dyne Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dyne Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Dyne Therapeutics Short Properties
Dyne Therapeutics' future price predictability will typically decrease when Dyne Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dyne Therapeutics often depends not only on the future outlook of the potential Dyne Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dyne Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 94.1 M | |
| Cash And Short Term Investments | 642.3 M |
Check out Historical Fundamental Analysis of Dyne Therapeutics to cross-verify your projections. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Will Stock sector continue expanding? Could Dyne diversify its offerings? Factors like these will boost the valuation of Dyne Therapeutics. Projected growth potential of Dyne fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Dyne Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Dyne Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dyne Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Dyne Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.